Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient.

BMC Gastroenterol · 2017 · PMC5717845 · PMID 29207968

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the PRODIGE 4 trial, the subgroup analysis showed no hint for a worse survival for patients between 65 and 74 years [ 13 ] and also in our analysis, the difference in OS for the age groups did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.